News Focus
News Focus
icon url

m1ocha

07/05/22 9:33 AM

#17337 RE: stervc #17336

Thanks for this. Buying more this morning.
icon url

learningthetruth

07/05/22 9:38 AM

#17339 RE: stervc #17336

Incredible DD Sterling....

greatly appreciated!!!
icon url

Truenorth2016

07/05/22 9:51 AM

#17342 RE: stervc #17336

stervc, I didnt even think to research the origin of the approval of Puriblood FDA Device and it is right there for all to see. They told us in the PR they have not sold one device yet (summarizing), which they are now allowed to sell in the North, South and Central Americas bringing in more revenues. It is very wishful thinking but it wont surprise me to see they have a deal/contract in the North, South, Central Americas already lined up and waiting for some things to be set in place.....
icon url

Truenorth2016

07/05/22 9:55 AM

#17344 RE: stervc #17336

stervc you said:
"when you are acquiring all rights to the licensing and distribution of something like this for 30 years as per the PR, it is huge because you acquire the revenue flow of how the money will be made while not acquiring all or any of the expenses that are associated with the acquisition.

This is why I believe the PLPL CEO said in a previous recent PR that he was "optimistic" about the June 30th 2022 ending of the fiscal year. Why would he be happy about this when PLPL has not products until they officially merge? I think he is talking in code and accidently slipped that Puriblood product revenues is being counted in that June 30th fiscal year.
icon url

JPS02

07/05/22 8:20 PM

#17433 RE: stervc #17336

NOTE 8 – EQUITY TRANSACTIONS - Extract

On January 27, 2022, EMA Financial, LLC sold its remaining $68,397.30 of accrued interest of its convertible debt to Pinnacle Consulting Services, Inc., in exchange for $60,000 per a Purchase and Assignment Agreement dated January 26, 2022.

On May 10, 2022, Pinnacle Consulting Services, Inc. executed a debt conversion resulting in the issuance of 200,000,000 shares of common stock. This debt conversion reduced the principal and interest balances of their convertible note payable to $0 and $38,397.30, respectively, as of June 30, 2022.

Extract source - PLPL June 30, 2022 Annual Report: https://www.otcmarkets.com/otcapi/company/financial-report/338972/content

Go PLPL!
icon url

QTRADERQ

07/17/22 7:14 PM

#18419 RE: stervc #17336

Puriblood has an internal sales team for domestic and international sales. That is a fact. The assumption that Jessie Chiang has exclusive worldwide rights to resell their product is false based on the information I’ve researched.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169422146

I’ve sent an email to the person in charge of international sales and marketing at Puriblood and will share it with the board when it’s received.

JMO